Copyright

Printer version

Send to a friend

Text size

© 2007 Solvay Pharmaceuticals, Inc.

All rights reserved and protected under U.S. Copyright Law. No part of this work may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying and recording, or by any information storage or retrieval system without the prior approval of Solvay Pharmaceuticals, Inc., unless such copying is expressly permitted by federal copyright law. Such provisions will be strictly enforced.


		AndroGel is indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone. Safety information: AndroGel must not be used by women. You should not use AndroGel if you have any of these conditions: Prostate cancer (if your doctor knows for sure that you have it or thinks you may) Breast cancer (a rare condition for men) Warning: Elderly patients treated with androgens may be at an increased risk for the development of an enlarged prostate and prostate cancer. The most frequent adverse events reported by ≥5% of patients associated with the consistent use of AndroGel included abnormal lab test, acne, prostate disorder, and application site reaction. Remember, the information on this website does not take the place of the advice you get from your doctor or other health care professional. Always talk with your doctor if you have questions about AndroGel. Please see full Prescribing Information and Patient Information.

This information is intended for residents of the United States.
For international product information please visit us at http://www.solvay.com.
© 2007 Solvay Pharmaceuticals, Inc.